What it is
Bifidobacterium infantis 35624 is a specific probiotic strain clinically studied for Irritable Bowel Syndrome (IBS). It is formulated in capsule form to support digestive comfort and the integrity of the gut lining.
5 billion CFU · vegan · gluten-free · 30 caps
Affiliate link · we earn from qualifying purchases. No paid placements.
Bifidobacterium infantis 35624 is a specific probiotic strain clinically studied for Irritable Bowel Syndrome (IBS). It is formulated in capsule form to support digestive comfort and the integrity of the gut lining.
This probiotic strain modulates the gut microbiome, contributing to improved digestive function. Its effects on gut comfort are dose-dependent, typically becoming noticeable within 1-4 weeks of consistent daily intake.
Adults looking to address bloating, indigestion, irregular bowel movements. Particularly relevant for people who prefer a targeted single ingredient and who have ruled out an underlying condition that needs medical care first.
Pregnant or nursing women without clinician oversight. People on prescription medication affecting the same pathway should consult a doctor before combining. Side effects are uncommon at recommended doses but mild GI upset can occur when starting.
C · C · emerging-to-moderate human evidence for digestive comfort and gut-barrier integrity
SacredBod's longer take on Bifidobacterium infantis 35624 — context the structured blocks above don't capture.
Bifidobacterium infantis 35624 is a probiotic supplement used to support digestive comfort and gut-barrier integrity. Clinically studied strain for IBS. It is available in capsule form and dosed for adults in India and internationally. As a western-tradition entry in the SacredBod catalog, it is positioned as a single-ingredient option that can be used on its own or layered into a broader protocol. Bifidobacterium infantis 35624 works through the mechanisms characteristic of its class — see the mechanism and research sections for detail. It primarily acts on the gut, intestines, stomach, and effects are dose-dependent, typically becoming measurable within 1-4 weeks for digestive comfort. Consistency matters more than dose size for this category.
Bifidobacterium infantis 35624 carries an evidence grade of C in the SacredBod catalog, reflecting emerging human evidence for digestive comfort and gut-barrier integrity. Clinically studied strain for IBS. Benefits are cumulative rather than immediate, typically becoming noticeable within 1-4 weeks for digestive comfort, and individual response varies.
A typical dose is 5 billion CFU, taken with food, usually in the morning. Start at the lower end, assess tolerance, and stay consistent; more is not automatically better.
Pregnant or nursing women without clinician oversight. People on prescription medication affecting the same pathway should consult a doctor before combining. Side effects are uncommon at recommended doses but mild GI upset can occur when starting.
Adults looking to address bloating, indigestion, irregular bowel movements. Particularly relevant for people who prefer a targeted single ingredient and who have ruled out an underlying condition that needs medical care first.
As part of the Probiotic category, Bifidobacterium infantis 35624 can be used on its own or layered into a broader protocol — see the Goes with panel for evidence-aligned pairings.
Peptides are physician-only. Tell us a bit and we'll route you to the right specialist.
Request received.
We'll route this to a clinician familiar with peptide protocols. Expect a reply within about 48 hours.
How's your experience? We read every note.